van den Heerik, Anne Sophie V M https://orcid.org/0000-0001-6403-0143
Horeweg, Nanda https://orcid.org/0000-0002-8581-4753
Nout, Remi A
Lutgens, Ludy C H W
van der Steen-Banasik, Elzbieta M
Westerveld, G Henrike
van den Berg, Hetty A
Slot, Annerie
Koppe, Friederike L A
Kommoss, Stefan
Mens, Jan Willem M
Nowee, Marlies E
Bijmolt, Stefan
Cibula, David
Stam, Tanja C
Jurgenliemk-Schulz, Ina M
Snyers, An
Hamann, Moritz
Zwanenburg, Aleida G
Coen, Veronique L M A
Vandecasteele, Katrien
Gillham, Charles
Chargari, Cyrus
Verhoeven-Adema, Karen W
Putter, Hein
van den Hout, Wilbert B
Wortman, Bastiaan G
Nijman, Hans W
Bosse, Tjalling
Creutzberg, Carien L
Clinical trials referenced in this document:
Documents that mention this clinical trial
Molecular typing guiding treatment and prognosis of endometrial cancer
https://doi.org/10.1016/j.gocm.2023.01.011
Adjuvant chemotherapy and radiation for patients with high-risk stage I endometrial cancer treated with curative intent surgery: impact on recurrence and survival
https://doi.org/10.1136/ijgc-2021-003087
The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers
https://doi.org/10.1136/ijgc-2022-003709
Advances in the management of endometrial cancer
https://doi.org/10.1136/bmj-2024-080978
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
https://doi.org/10.1136/ijgc-2020-001822
Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy
https://doi.org/10.1136/ijgc-2021-002380
Biomarker-driven therapy in endometrial cancer
https://doi.org/10.1136/ijgc-2022-003676
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
https://doi.org/10.1136/ijgc-2020-001929
Funding for this research was provided by:
KWF Kankerbestrijding (UL2011-5336 and 12376)
This article is maintained by: Elsevier
Article Title: PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
Journal Title: International Journal of Gynecological Cancer
CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/ijgc-2020-001929
Content Type: article
Copyright: Copyright This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.